678 related articles for article (PubMed ID: 22580627)
21. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.
Bedair R; Babu-Narayan SV; Dimopoulos K; Quyam S; Doyle AM; Swan L; Gatzoulis MA; Wong T
Int J Cardiol; 2015 Feb; 181():218-24. PubMed ID: 25528316
[TBL] [Abstract][Full Text] [Related]
22. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
[TBL] [Abstract][Full Text] [Related]
23. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
Pedersen SS; Theuns DA; Jordaens L; Kupper N
Europace; 2010 Aug; 12(8):1119-26. PubMed ID: 20507853
[TBL] [Abstract][Full Text] [Related]
24. Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study.
Vazquez LD; Kuhl EA; Shea JB; Kirkness A; Lemon J; Whalley D; Conti JB; Sears SF
Pacing Clin Electrophysiol; 2008 Dec; 31(12):1528-34. PubMed ID: 19067804
[TBL] [Abstract][Full Text] [Related]
25. [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].
Shiyovich A; Ben Zion IZ; Plakht Y; Amit G; Grosbard A; Katz A
Harefuah; 2007 Aug; 146(8):594-8, 647. PubMed ID: 17853553
[TBL] [Abstract][Full Text] [Related]
26. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator.
Cho EN; von Känel R; Marten-Mittag B; Ronel J; Kolb C; Baumert J; Ladwig KH
Heart; 2012 May; 98(10):806-12. PubMed ID: 22543838
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
DeMaso DR; Lauretti A; Spieth L; van der Feen JR; Jay KS; Gauvreau K; Walsh EP; Berul CI
Am J Cardiol; 2004 Mar; 93(5):582-7. PubMed ID: 14996583
[TBL] [Abstract][Full Text] [Related]
28. Psychological implications of ICD implantation in a New Zealand population.
Newall EG; Lever NA; Prasad S; Hornabrook C; Larsen PD
Europace; 2007 Jan; 9(1):20-4. PubMed ID: 17224417
[TBL] [Abstract][Full Text] [Related]
29. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
[TBL] [Abstract][Full Text] [Related]
30. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.
Bostwick JM; Sola CL
Psychiatr Clin North Am; 2007 Dec; 30(4):677-88. PubMed ID: 17938040
[TBL] [Abstract][Full Text] [Related]
31. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
Hoogwegt MT; Kupper N; Theuns DA; Jordaens L; Pedersen SS
Europace; 2012 Jan; 14(1):74-80. PubMed ID: 21920910
[TBL] [Abstract][Full Text] [Related]
32. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors.
Bilge AK; Ozben B; Demircan S; Cinar M; Yilmaz E; Adalet K
Pacing Clin Electrophysiol; 2006 Jun; 29(6):619-26. PubMed ID: 16784428
[TBL] [Abstract][Full Text] [Related]
33. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
Johansen JB; Pedersen SS; Spindler H; Andersen K; Nielsen JC; Mortensen PT
Europace; 2008 May; 10(5):545-51. PubMed ID: 18378633
[TBL] [Abstract][Full Text] [Related]
34. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
Luyster FS; Hughes JW; Gunstad J
J Cardiovasc Nurs; 2009; 24(1):10-7. PubMed ID: 19114795
[TBL] [Abstract][Full Text] [Related]
35. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.
Undavia M; Goldstein NE; Cohen P; Sinthawanarong K; Singson M; Bhutani D; Munson T; Gomes JA; Fischer A; Mehta D
Pacing Clin Electrophysiol; 2008 Nov; 31(11):1411-8. PubMed ID: 18950298
[TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator.
Crössmann A; Schulz SM; Kühlkamp V; Ritter O; Neuser H; Schumacher B; Bauer W; Pauli P
Psychosom Med; 2010 Jun; 72(5):434-41. PubMed ID: 20410252
[TBL] [Abstract][Full Text] [Related]
37. Self-reported adjustment to implanted cardiac devices.
Beery TA; Baas LS; Henthorn C
J Cardiovasc Nurs; 2007; 22(6):516-24. PubMed ID: 18090194
[TBL] [Abstract][Full Text] [Related]
38. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
[TBL] [Abstract][Full Text] [Related]
39. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
Luyster FS; Hughes JW; Waechter D; Josephson R
Psychosom Med; 2006; 68(5):794-800. PubMed ID: 17012535
[TBL] [Abstract][Full Text] [Related]
40. [Impact of attachment style, social support and the number of implantable cardioverter defibrillator (ICD) discharges on psychological strain of ICD patients].
Simson U; Perings C; Plaskuda A; Schäfer R; Brehm M; Bader D; Tress W; Franz M
Psychother Psychosom Med Psychol; 2006 Dec; 56(12):493-9. PubMed ID: 17160793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
